Cargando…
Why do men with prostate cancer discontinue active surveillance for definitive treatment? A mixed methods investigation
OBJECTIVES: To explore the personal and/or medical reasons patients on active surveillance (AS) have, or consider having, further definitive treatment for their prostate cancer. Research suggests up to 50% of patients on AS will discontinue within 5 years, though reasons for discontinuation from the...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540004/ https://www.ncbi.nlm.nih.gov/pubmed/35538736 http://dx.doi.org/10.1002/pon.5947 |